![Eric Poma](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Poma
Directeur Général chez
CALIDI BIOTHERAPEUTICS, INC.
Fortune : 4 625 $ au 31/05/2026
Profil
Eric E.
Poma is the founder of Molecular Templates, Inc., founded in 2000, where the titles held included CEO, CFO, CAO, Treasurer, Director, and CSO in 2024.
Current jobs include Chief Executive Officer and Director at Molecular Templates OpCo, Inc.; Chief Executive Officer and Director at Calidi Biotherapeutics, Inc. starting in 2025; and Chairman and Chief Executive Officer at Calidi Biotherapeutics (Nevada), Inc. starting in 2025.
Former jobs include Vice President-Business Development at ImClone LLC from 2001 to 2013 and Secretary and Vice President-Business Development at Innovive Pharmaceuticals, Inc. from 2009 to 2013.
Education history includes an MBA from The Leonard N Stern School of Business and undergraduate and doctorate degrees from the University of North Carolina at Chapel Hill.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/04/2026 | 25 000 ( 0,7 % ) | 4 625 $ | 31/05/2026 |
Postes actifs de Eric Poma
| Sociétés | Poste | Début |
|---|---|---|
| CALIDI BIOTHERAPEUTICS, INC. | Directeur Général | 22/04/2025 |
Molecular Templates OpCo, Inc.
 Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Functions as an investment holding company | Directeur Général | - |
Calidi Biotherapeutics, Inc. (United States)
 Calidi Biotherapeutics, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage immuno-oncology company | Directeur Général | 22/04/2025 |
Anciens postes connus de Eric Poma
| Sociétés | Poste | Fin |
|---|---|---|
| MOLECULAR TEMPLATES, INC. | Directeur Général | 31/12/2024 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Corporate Officer/Principal | - |
Innovive Pharmaceuticals, Inc.
 Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Corporate Officer/Principal | - |
Formation de Eric Poma
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
15
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
Innovive Pharmaceuticals, Inc.
Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Templates, Inc.
 Molecular Templates, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Commercial Services |
Calidi Biotherapeutics, Inc. (United States)
Calidi Biotherapeutics, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage immuno-oncology company | Commercial Services |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Calidi Biotherapeutics, Inc.
 Calidi Biotherapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies which attacks solid tumors | Health Technology |
University of North Carolina at Chapel Hill
 University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Choisissez Zonebourse 
